These results demonstrate that mUTR2-mediated inhibition of SHMT2 significantly suppresses tumor growth in vivo, validating the use of this RNA-based inhibitor to target SHMT2 in the mitochondria in the animal model. This evidence concerns the gene SHMT2 and neoplasm.